Skip to main content
OpenTrials

Clinical trial condition

Prostatic Diseases

Explore clinical trials studying Prostatic Diseases. Study availability and eligibility vary by location and protocol.

5,354 public trials 1,052 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Diseases trial results

Completed

RESIST-ADT (Androgen Deprivation Therapy)

NCT04485767

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

NCT03016312

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • City of Hope Medical Grp Inc. Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
  • Kaiser Permanente San Diego - Los Angeles Los Angeles, California, United States
  • UC Irvine Medical Center Orange, California, United States
View all 158 locations
View Trial Details
Completed

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

NCT03902080

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Private Practice Huntsville, Alabama, United States
  • Coastal Clinical Research, Inc. Mobile, Alabama, United States
  • Gen1 Research- Arizona Urology Specialists Glendale, Arizona, United States
View all 140 locations
View Trial Details
Completed

A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate

NCT01685268

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of California, Los Angeles Institute of Urologic Oncology Los Angeles, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Florida Cancer Specialists-Fort Myers Fort Myers, Florida, United States
View all 32 locations
View Trial Details

Related conditions